BFC Planning’s FibroBiologics FBLG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$65 Hold
50
– – ﹤0.01% 3405
2026
Q2
$47 Hold
50
– – ﹤0.01% 3377
2026
Q1
$66 Hold
50
– – ﹤0.01% 2982
2025
Q4
$225 Hold
50
– – ﹤0.01% 3022
2025
Q3
$546 Buy
+50
New +$599 ﹤0.01% 2735

Other funds holding FBLG

BFC Planning's FBLG Position: Q3 2026 in Review

BFC Planning held its FibroBiologics (FBLG) position steady in Q3 2026 at 50 shares worth $65. The position accounts for ﹤0.01% of the portfolio, ranked #3405.

BFC Planning first reported a position in FBLG in Q3 2025 and has held it in 5 quarters since. The position peaked at $546 in Q3 2025. 14 funds tracked by Wall St. Rank hold FBLG as of Q3 2026.

  • BFC Planning held 50 shares of FibroBiologics worth $65 as of Q3 2026.
  • BFC Planning left its FibroBiologics share count unchanged in Q3 2026.
  • FibroBiologics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3405 holding.
  • BFC Planning first reported a position in FibroBiologics in Q3 2025 and has held it in 5 quarters since.
  • BFC Planning's FibroBiologics position peaked at $546 in Q3 2025.
  • 14 funds tracked by Wall St. Rank held FibroBiologics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.